Irmgard Maria Rita Hofmann

Title: Irmgard Maria Rita Hofmann: Innovator in Antibody Research

Introduction

Irmgard Maria Rita Hofmann is a notable inventor based in Vienna, Austria. She has made significant contributions to the field of antibody research, particularly in the development of therapeutic applications for cancer diseases. Her innovative work has led to the creation of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Irmgard holds a patent for an antagonizing CD73 antibody. This invention relates to novel antagonizing antibodies for CD73, which are crucial for therapeutic purposes in cancer treatment. The patent also encompasses nucleic acids encoding such antibody molecules, methods for preparing these molecules, and host cells capable of expressing them. Additionally, it includes compositions comprising these antibody molecules and their various uses in the medical field.

Career Highlights

Irmgard is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. Her role at the company allows her to collaborate with other talented professionals in the field of biotechnology and pharmaceuticals.

Collaborations

Some of her notable coworkers include Melanie Wurm and Jennifer Ahlberg. Their collaborative efforts contribute to the innovative environment at Boehringer Ingelheim, fostering advancements in therapeutic research.

Conclusion

Irmgard Maria Rita Hofmann is a pioneering inventor whose work in antibody research has the potential to impact cancer treatment significantly. Her dedication to innovation and collaboration exemplifies the spirit of scientific advancement in the medical field.